-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Elevance Health, Maintains $478 Price Target

Benzinga·04/23/2025 16:42:45
Listen to the news
RBC Capital analyst Ben Hendrix reiterates Elevance Health (NYSE:ELV) with a Outperform and maintains $478 price target.